| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |